FindTrial
Sign In

MANAGEMENT OF INFECTED WOUND (NON-HEALING ULCER)IN PATIENTS OF AGE GROUP 18 TO 60 YEARS BY HIGH-FREQUENCY ELECTROTHERAPY AND AGNIKARMA

MANAGEMENT OF DUSHTAVRANA (NON-HEALING ULCER)BY HIGH FREQUENCY ELECTROTHERAPY AND AGNIKARMA-A COMPARATIVE RANDOMIZED CLINICAL CONTROL STUDY IN 18 TO 60 YEARS OF AGE - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079747
Enrollment
60
Registered
2025-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: HIGH-FREQUENCY ELECTROTHERAPY: The high frequency is used for skin, scalp and body treatment which has many benefits including treating acne, enlarged pores, fine lines, wounds and ulc

Sponsors

DMM Ayurved Mahavidyalaya,Yavatmal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients of the age group 18-60 years. 2. The patients with symptoms of Dushtavrana irrespective of its dosha E.g.Shul, Kandu, Strava, Gandh, Sparshasahtva. 3. Patients of any sex will be selected. 4. Marital Status – Both 5. Patient only of pre-diagnosed Dushtavrana. 6. Patient belonging to any socio-economic class.

Exclusion criteria

Exclusion criteria: 1. Age group below 18 years and above 60 years. 2. Pregnant and lactating mother. 3. Patients with other systemic diseases such as AIDS, TB, Diabetes Mellitus, Malignancy, and Leprosy may affect the outcome of the treatment. 4. Ulcers with gangrenous changes. 5. Patient not willing to participate in study. 6. Osteomyelitis wounds. 7. Dagdha Vrana.

Design outcomes

Primary

MeasureTime frame
The parameters will be noted down before and after treatment. 1. Vedana (Severity of pain) 2. Kandu (Itching) 3. Gandh (Smell) 4. Strava (Discharge) 5. Sparshasahtva (Tenderness)Timepoint: 0th, 7th,14st and 21th (28th follow up) and then Follow up will be taken on 45th days to observe recurrence)—

Secondary

MeasureTime frame
1) No improvement - 0 % relief in signs and symptoms. 2) Poor improvement - 0%-25% relief in sign and symptoms. 3) Mild improvement – 26% to 50% relief in signs and symptoms. 4) Moderate improvement – 51% to 75 % relief in signs and symptoms. 5) Marked improvement – 76% to 100% relief in signs and symptoms.Timepoint: 0th, 7th,14st and 21th (28th follow up) and then Follow up will be taken on 45th days to observe recurrence)—

Countries

India

Contacts

Public ContactDrPravin Bhaurao Chetule

Dayabhai Maoji Majithiya Ayurved Mahavidyalaya and L.K.Ayurved Rugnalaya,Yavatmal

drviharbidwai@gmail.com9822299174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026